USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| - | Sep 30, 2021 | - | $-0.28 | - |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| - | Sep 30, 2021 | - | $14.58M | $7.42M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-0.95 | $-1.03 | $-0.88 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $-2.57 | $-2.62 | $-2.52 |
| Dec 2022 | 3 | $-3.68 | $-4.32 | $-2.88 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.95 | $-0.95 | $-0.84 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-2.62 | $-2.62 | $-2.84 |
| Dec 2022 | 0 / 0 | $-3.60 | $-3.60 | $-2.98 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $170.00K | $0.00 | $350.00K |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 2 | $16.93M | $16.58M | $17.28M |
| Dec 2022 | 2 | $1.55M | $0.00 | $3.10M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 12, 2021 | Jun 2021 | $-0.68 | $-0.28 | 58.82% |
| May 13, 2021 | Mar 2021 | $-1.10 | $-0.61 | 44.55% |
| Mar 25, 2021 | Dec 2020 | $-0.66 | $-1.85 | -180.30% |
| Dec 31, 2019 | Sep 2019 | - | $-3.12 | - |
| Sep 30, 2019 | Jun 2019 | - | $-3.24 | - |
| Jun 30, 2019 | Mar 2019 | - | $-1.61 | - |
| Mar 31, 2019 | Dec 2018 | - | $-1.61 | - |
| Dec 31, 2018 | Sep 2018 | - | $-0.43 | - |
| Sep 30, 2018 | Jun 2018 | - | $-0.43 | - |
| Jun 30, 2018 | Mar 2018 | - | $-0.52 | - |
| Mar 31, 2018 | Dec 2017 | - | $-0.52 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $-3.01 | $-9.82 | - |
| Mar 31, 2019 | Dec 2018 | - | $-2.98 | - |
| Mar 31, 2018 | Dec 2017 | - | $-0.52 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 12, 2021 | Jun 2021 | $14.58M | $14.58M | 1.00% |
| May 13, 2021 | Mar 2021 | $0.00 | $2.00M | - |
| Mar 25, 2021 | Dec 2020 | $0.00 | $-977.00K | - |
| Dec 31, 2019 | Sep 2019 | - | - | - |
| Sep 30, 2019 | Jun 2019 | - | - | - |
| Jun 30, 2019 | Mar 2019 | - | - | - |
| Mar 31, 2019 | Dec 2018 | - | - | - |
| Dec 31, 2018 | Sep 2018 | - | - | - |
| Sep 30, 2018 | Jun 2018 | - | - | - |
| Jun 30, 2018 | Mar 2018 | - | - | - |
| Mar 31, 2018 | Dec 2017 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $13.61M | $13.61M | 0.00% |
| Mar 31, 2019 | Dec 2018 | - | $14.13M | - |
| Mar 31, 2018 | Dec 2017 | - | $5.79M | - |
4d Molecular Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
FDMT's earnings per share (EPS) was $-0.28, beating the consensus analysts forecast of $-0.68 by 58.82%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -54.10%.
Revenues were $14.58M, better than the forecast of $14.58M by 0.00%, up by 629.00% from the previous quarter , and up by 301.32% from the same period last year.
The company reported a net income of $-7.59M.Free cash flow for the quarter was $-16.94M , compared to $-16.01M last quarter and $-6.29M a year before.
4d Molecular Therapeutics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.
FDMT's earnings per share (EPS) was $-9.82.
Revenues were $13.61M, better than the forecast of $13.61M by 0.00%, and up by 94.85% from previous year's revenue.
The company reported a net income of $-56.69M.
4d Molecular Therapeutics, Inc reported a free cash flow of $-51.91M for its fiscal year, compared to $-39.91M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
